Royalty Pharma (RPRX) FCF Margin Growth (1y) (2020 - 2026)
Royalty Pharma (RPRX) FCF Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Royalty Pharma |
23.13 Bn |
25.57 Bn |
- |
-6,255.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-6,255.00 |
| Dec 31, 2025 |
-2,643.00 |
| Sep 30, 2025 |
4,439.00 |
| Jun 30, 2025 |
7,582.00 |
| Mar 31, 2025 |
285.00 |
| Dec 31, 2024 |
7,998.00 |
| Sep 30, 2024 |
-10,976.00 |
| Jun 30, 2024 |
-11,481.00 |
| Mar 31, 2024 |
3,868.00 |
| Dec 31, 2023 |
-9,503.00 |
| Sep 30, 2023 |
15,840.00 |
| Jun 30, 2023 |
2,708.00 |
| Mar 31, 2023 |
-1,870.00 |
| Dec 31, 2022 |
123.00 |
| Sep 30, 2022 |
1,231.00 |
| Jun 30, 2022 |
1,137.00 |
| Mar 31, 2022 |
7,786.00 |
| Dec 31, 2021 |
9,713.00 |
| Sep 30, 2021 |
-9,335.00 |
| Jun 30, 2021 |
6,058.00 |
